Benzinga | Sep 17, 2020 08:45AM EDT

JMP Securities Initiates Coverage On Spectrum Pharmaceuticals with Outperform Rating, Announces Price Target of $12

JMP Securities analyst Reni Benjamin initiates coverage on Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Outperform rating and announces Price Target of $12.JMP Securities analyst Reni Benjamin initiates coverage on Spectrum Pharmaceuticals (NASDAQ:SPPI) with a Outperform rating and announces Price Target of $12.